drugset / Trial / NCT06604949
A Study of Single Dose of LP-003 in Healthy Adult Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy subjects.
Timeline
- Start
- 2024-10-23
- Primary completion
- 2026-11
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LP-003 | Unknown | 200 mg | Subcutaneous |